479 related articles for article (PubMed ID: 11739748)
1. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
2. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
[TBL] [Abstract][Full Text] [Related]
3. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
Tago K; Chiocca S; Sherr CJ
Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
[TBL] [Abstract][Full Text] [Related]
4. p53-independent apoptosis is induced by the p19ARF tumor suppressor.
Tsuji K; Mizumoto K; Sudo H; Kouyama K; Ogata E; Matsuoka M
Biochem Biophys Res Commun; 2002 Jul; 295(3):621-9. PubMed ID: 12099684
[TBL] [Abstract][Full Text] [Related]
5. Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues.
O'Leary KA; Mendrysa SM; Vaccaro A; Perry ME
Mol Cell Biol; 2004 Jan; 24(1):186-91. PubMed ID: 14673154
[TBL] [Abstract][Full Text] [Related]
6. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
Russell JL; Weaks RL; Berton TR; Johnson DG
Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
[TBL] [Abstract][Full Text] [Related]
7. p14(ARF) regulates E2F activity.
Mason SL; Loughran O; La Thangue NB
Oncogene; 2002 Jun; 21(27):4220-30. PubMed ID: 12082609
[TBL] [Abstract][Full Text] [Related]
8. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
Aslanian A; Iaquinta PJ; Verona R; Lees JA
Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
[TBL] [Abstract][Full Text] [Related]
9. ARF differentially modulates apoptosis induced by E2F1 and Myc.
Russell JL; Powers JT; Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Mol Cell Biol; 2002 Mar; 22(5):1360-8. PubMed ID: 11839803
[TBL] [Abstract][Full Text] [Related]
10. Immortalization of human mammary epithelial cells is associated with inactivation of the p14ARF-p53 pathway.
Shamanin VA; Androphy EJ
Mol Cell Biol; 2004 Mar; 24(5):2144-52. PubMed ID: 14966292
[TBL] [Abstract][Full Text] [Related]
11. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
Palmero I; Murga M; Zubiaga A; Serrano M
Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
[TBL] [Abstract][Full Text] [Related]
12. E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.
Rogoff HA; Pickering MT; Debatis ME; Jones S; Kowalik TF
Mol Cell Biol; 2002 Aug; 22(15):5308-18. PubMed ID: 12101227
[TBL] [Abstract][Full Text] [Related]
13. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
14. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
15. CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53.
Hasan MK; Yaguchi T; Sugihara T; Kumar PK; Taira K; Reddel RR; Kaul SC; Wadhwa R
J Biol Chem; 2002 Oct; 277(40):37765-70. PubMed ID: 12154087
[TBL] [Abstract][Full Text] [Related]
16. The role of the transcription factor DP in apoptosis.
Hitchens MR; Robbins PD
Apoptosis; 2003 Oct; 8(5):461-8. PubMed ID: 12975577
[TBL] [Abstract][Full Text] [Related]
17. ARF function does not require p53 stabilization or Mdm2 relocalization.
Korgaonkar C; Zhao L; Modestou M; Quelle DE
Mol Cell Biol; 2002 Jan; 22(1):196-206. PubMed ID: 11739734
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
Lin AW; Lowe SW
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
[TBL] [Abstract][Full Text] [Related]
19. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ
PLoS Biol; 2004 Aug; 2(8):E242. PubMed ID: 15314658
[TBL] [Abstract][Full Text] [Related]
20. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.
Shvarts A; Brummelkamp TR; Scheeren F; Koh E; Daley GQ; Spits H; Bernards R
Genes Dev; 2002 Mar; 16(6):681-6. PubMed ID: 11914273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
